The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date

Nursing and Health Professions

• Patient 100%
• Follow up 27%
• Prostate Cancer 22%
• Data Base 16%
• Time 16%
• Biopsy 11%
• Nuclear Magnetic Resonance Imaging 11%
• Patient Coding 11%
• Non Profit Organization 11%
• Quality of Life 5%
• Treatment Outcome 5%
• Diagnosis 5%
• Diseases 5%
• Clinician 5%
• Prostate Specific Antigen 5%
• Neoplasm 5%
• Gleason Score 5%
• Evaluation Study 5%
• Procedures 5%
• Monitoring 5%
• Marker 5%
• Consensus 5%

Medicine and Dentistry

• Surveillance 55%
• Follow up 27%
• Prostate Cancer 22%
• Man 22%
• Magnetic Resonance Imaging 11%
• Therapeutic Procedure 11%
• Diagnosis 5%
• Neoplasm 5%
• Diseases 5%
• Demography 5%
• Prostate Specific Antigen 5%
• Clinical Stage 5%
• Evaluation Study 5%
• Age 5%
• Cumulative Incidence 5%
• Gleason Score 5%
• Prostate Cancer Diagnosis 5%
• Monitoring 5%
• Marker 5%
• Consensus 5%

Biochemistry, Genetics and Molecular Biology

• Data Base 16%
• Time 16%
• Patient Coding 11%
• Magnetic Resonance Imaging 11%
• Prostate-Specific Antigen 5%
• Demography 5%
• Gleason Score 5%
• Age 5%
• Life 5%
• Incidence 5%
• Consensus 5%